Volume 11, Issue 3 (9-2022)
JCHR 2022, 11(3): 165-174 |
Back to browse issues page
1- Instructor of Psychiatric Nursing - Faculty of nursing, North Khorasan University of Medical Sciences, Bojnurd, Iran
2- Instructor in Nursing, Faculty of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
3- Evidence Based Care Research Centre, Instructor of Psychiatric Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
4- Feculty of nursing, North Khorasan University of Medical Sciences, Bojnurd, Iran , ahamedi1364@gmail.com
2- Instructor in Nursing, Faculty of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
3- Evidence Based Care Research Centre, Instructor of Psychiatric Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
4- Feculty of nursing, North Khorasan University of Medical Sciences, Bojnurd, Iran , ahamedi1364@gmail.com
Abstract: (988 Views)
Background: Chronic and prolonged illnesses and disorders, such as addiction, lead to a crisis in the lives of people with disabilities and can lead to a decrease in their quality of life. Therefore, in this study, we decided to compare the quality of life of individuals with substance use disorders who participate in Narcotics Anonymous, therapeutic Community session with Methadone-treated groups.
Methods: This cohort study was conducted on detoxified patients attending Narcotics anonymous, therapeutic community sessions and Methadone-treated place. Quality of life of subjects measured at baseline and 1.5 months after the start of treatment. Data were analyzed by SPSS19 software using ANOVA, paired t-test, Chi-square analysis.
Results: The mean score of quality of life between three groups was not significantly different at the beginning of the study, but the mean score of quality of life among individuals with substance use disorders participating in the sessions of Narcotics anonymous and therapeutic community group increased significantly (P <0.001) 1.5 months after the start of treatment.
Conclusion: The results of this study indicate that the presence of detoxified persons in sessions of Narcotics anonymous and therapeutic community was effective in improving their quality of life. However, this effect is greater in Narcotics Anonymous. Therefore it was suggested that individuals with substance use disorders participate in these meetings.
Methods: This cohort study was conducted on detoxified patients attending Narcotics anonymous, therapeutic community sessions and Methadone-treated place. Quality of life of subjects measured at baseline and 1.5 months after the start of treatment. Data were analyzed by SPSS19 software using ANOVA, paired t-test, Chi-square analysis.
Results: The mean score of quality of life between three groups was not significantly different at the beginning of the study, but the mean score of quality of life among individuals with substance use disorders participating in the sessions of Narcotics anonymous and therapeutic community group increased significantly (P <0.001) 1.5 months after the start of treatment.
Conclusion: The results of this study indicate that the presence of detoxified persons in sessions of Narcotics anonymous and therapeutic community was effective in improving their quality of life. However, this effect is greater in Narcotics Anonymous. Therefore it was suggested that individuals with substance use disorders participate in these meetings.
Review: Research |
Subject:
Health care management
Received: 2020/10/9 | Accepted: 2022/09/19 | Published: 2022/10/19
Received: 2020/10/9 | Accepted: 2022/09/19 | Published: 2022/10/19
References
1. Zare F, Ameri H, Madadizadeh F, Reza Aghaei M. Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus. SAGE Open Medicine. 2020 Oct;8:2050312120965314. [DOI:10.1177/2050312120965314]
2. Madadizade F, Sabermahani A. The comparison of quality of life among hem dialysis and peritoneal dialysis patients in Kerman. Journal of Health Based Research. 2015 Dec 10;1(2):95-104.
3. Rahmati A, Herfeh FZ, Hosseini SO. Barriers to Quitting Addiction in Iranian Women: A Qualitative Study. Iranian Red Crescent Medical Journal. 2019;21(5). [DOI:10.5812/ircmj.65976]
4. Egervari G, Ciccocioppo R, Jentsch JD, et al. Shaping vulnerability to addiction-the contribution of behavior, neural circuits and molecular mechanisms. Neuroscience & Biobehavioral Reviews. 2018;85:117-25. [DOI:10.1016/j.neubiorev.2017.05.019]
5. Seraji A, Momeni H, Salehi A. The investigation of factors affecting dependence on narcotics and reappearance of drug usage in narcotics anonymous population in Khomein. Arak Med Univ J. 2010;13(3):68e75.
6. Management of substance abuse. [cited http :// www.who.int/substance_abuse/facts/psychoactives/en/. html Accessed ]. 2018 [cited 2018 23 nov].
7. Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Current cardiology reports. 2019;21(4):21. [DOI:10.1007/s11886-019-1107-y]
8. Lotfi MH, Fallahzadeh H, Rahmanian M, et al. The role of clinical factors in the association of gestational diabetes amongst women aged 15-49 years residing in Yazd-Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(5):705-9. [DOI:10.1016/j.dsx.2018.04.021]
9. Number of drug addicts in Iran 'doubles' in six years. [cited https://www.independent.co.uk/news/world/middle-east/iran-tehran-drug-addiction-opium-heroin-afghanistan-taliban-a7809046.html ]. 2018 [26 June 2017].
10. Katibaei J, Hamidi H, Yarian S, et al. Comparison of quality of life, stress and mental health of addicts and non-addicts affected by HIV and healthy individuals. International Journal of Behavioral Sciences. 2010;4(2):135-9.
11. Emamipour S, Shams Esfandabad H, Sadrossadat S, et al. Comparison of life quality and psychological disorders in drug-using, drug-using HIV infected, non-drug using HIV infected and a reference group of healthy men. J Shahrekord Univ Med Sci. 2008; 10 (1) :69-77. URL: http://78.39.35.44/article-1-160-en.html
12. SHAMS EH, NEZHADNADERI S. A comparative study of the quality of life and religious attitude among Addicted/non-addicted individuals in Kerman City. 2009; 5(1):139-152.
13. Jordan CJ, Cao J, Newman AH, et al. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. Neuropharmacology. 2019;158:107609. [DOI:10.1016/j.neuropharm.2019.04.015]
14. Galanter M, White WL, Hunter BD. Cross-cultural applicability of the 12-Step model: A comparison of Narcotics Anonymous in the USA and Iran. Journal of Addiction Medicine. 2019;13(6):493. [DOI:10.1097/ADM.0000000000000526]
15. Doogan NJ, Warren KL. Saving my life: Dynamics of peer and staff corrections among therapeutic community residents. Substance use & misuse. 2017;52(11):1429-38. [DOI:10.1080/10826084.2017.1284236]
16. Kreager DA, Schaefer DR, Davidson KM, et al. Evaluating peer-influence processes in a prison-based therapeutic community: a dynamic network approach. Drug and alcohol dependence. 2019;203:13-8. [DOI:10.1016/j.drugalcdep.2019.05.018]
17. Dashtgerd A. Bandura's Social Ccognitive Theory, the Effect of the Withdrawal in Patients Admitted to Addiction Clinic of Imam Reza Hospital in Mashhad in 2010. [Thesis]: Mashhad University of Medical Science. ; 2010.
18. Bahariniya S, Ezatiasar M, Madadizadeh F. A Brief Review of the Types of Validity and Reliability of scales in Medical Research. Journal of Community Health Research. 2021 Mar 10;10(2):100-2. [DOI:10.18502/jchr.v10i2.6582]
19. Brazier JE, Harper R, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160-164. doi:10.1136/bmj.305.6846.160 [DOI:10.1136/bmj.305.6846.160]
20. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271-292. doi:10.1016/s0167-6296(01)00130-8. [DOI:10.1016/S0167-6296(01)00130-8]
21. Linde L, Sørensen J, Østergaard M, et al. Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. The Journal of Rheumatology. 2008;35(8):1528-37.
22. Zarebahramabadi M, Mohamadyfar MA, Erfani N,et al. The Comparison of the Effectiveness of Self-Acceptance Group Therapy By Draydan Method and NA Training on Addicts' Mental Health Components. Journal of Research on Addiction 2012 spring; 6(21): 81-99.
23. Beygi A, Mohammadyfar MA, Farahani MN, etal. The Comparative Study of Coping Styles and Hope among Narcotic Anonymous and Methadone Maintenance Treatment Members. Journal of Research on Addiction 2011 winter; 5(20): 55-72.
24. Sotodeh Asl N, Behnam B, Ghorbani R. Effectiveness of narcotics anonymous training programs in personality characters in substance abuse patients. Koomesh. 2013; 14 (3) :316-320 URL: http://koomeshjournal. semums.ac.ir/article-1-1674-en.html.
25. DeLucia C, Bergman BG, Beitra D, et al. Beyond abstinence: an examination of psychological well-being in members of narcotics Anonymous. J Happiness Stud. 2016;17(2):817-832. [DOI:10.1007/s10902-014-9609-1]
26. Toumbourou JW, Hamilton M, U'Ren A. Narcotics Anonymous participation and changes in substance use and social support. J Subst Abus Treat. 2002;23(1):61-66 [DOI:10.1016/S0740-5472(02)00243-X]
27. Jalali R, Moradi A, Dehghan F. The exploration of factors related to treatment retention in Narcotics Anonymous members: a qualitative study. Substance abuse treatment, prevention, and policy. 2019;14(1):1-9. [DOI:10.1186/s13011-019-0205-6]
28. Majer JM, Jason LA, Aase DM, Droege JR, Ferrari JR. Categorical 12-step involvement and continuous abstinence at 2 years. Journal of substance abuse treatment. 2013;44(1):46-51. [DOI:10.1016/j.jsat.2012.03.001]
29. Beygi A, FARAHANI M, MOHAMMADKHANI S, MOHAMMADIFAR MA. The Discriminative Role of Quality of Life and Hope in Narcotic Anonymous and Methadone Maintenance Groups. 2011;3(11):75-84.
30. BEYGI A. Piritual development, socio-religious performance and quality of life in narcotic anonymous. 2011;6(2):6-12.
31. HAJ HM, HASHEMI R. ADDICTS'QUALITY OF LIFE AND PSYCHOLOGICAL DISORDERS (DEPRESSION, ANXIETY, AND STRESS) IN TWO TREATMENT METHODS: NARCOTICS ANONYMOUS VS. METHADONE MAINTENANCE TREATMENT. RESEARCH ON ADDICTION. 2015 [cited 2022June14];9(35):119-136. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=486723
32. Aliverdinia A. The effectiveness of narcotics anonymouss' programs in the attitude of drug addicts. Iranian Social Studies. 2010;3(3):123-70.
33. Krentzman AR, Robinson EA, Moore BC, et al. How alcoholics anonymous (AA) and narcotics anonymous (NA) work: Cross-disciplinary perspectives. Alcoholism treatment quarterly. 2011;29(1):75-84. [DOI:10.1080/07347324.2011.538318]
34. Sadrosadat SJ, Kalateh ZM-R, Keldi A. A Study on the Association between Therapeutic Community Program and Social Relationship of Previously Addicated Persons. Journal of Rehabilitation. 2005;6(3):10-3.
35. Yarmohammadi Vasel M. The Efficacy of Therapeutic Community on Life Skills Improvement and Reduction of Relapse in Male Addicts. Journal of Kerman university of medical sciences 2011 autumn; 18(4): 358-368.
36. Karimnejad F, Maktabi G, Vatankhah M. Comparison between agreeableness trait of personality and spiritual health of the addicts living in community treatment centers (TC) and under methadone treatment addicts in Ahvaz, Iran. Bimonthly Journal of Hormozgan University of Medical Sciences. 2014;18(1):75-83.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution 4.0 International License. |